Oxalic Acid for Interference Testing

<strong>Oxalic Acid for Interference Testing</strong>_x000D_ <strong>Catalog number:</strong> C2010411_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 500 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> 90.03 (g/mol)_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Appearance:</strong> White solid_x000D_ <strong>Applications:</strong> waste product of metabolism that the body disposes of in the urine. Because of its poor solubility, oxalic acid often forms crystals in urine._x000D_ <strong>Storage:</strong> Room Temperature_x000D_ <strong>Keywords:</strong> Ethanedioic Acid, oxalate_x000D_ <strong>Grade:</strong> Biotechnology grade. All solid components are highly pure (minimum 95%). All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Goldstein BN, Wesler J, Nowacki AS, Reineks E, Natowicz MR. Investigations of_x000D_ blood ammonia analysis: Test matrices, storage, and stability. Clin Biochem._x000D_ 2017 Jun;50(9):537-539._x000D_ _x000D_ 2: Turkmen K, Erdur FM. The relationship between colonization of Oxalobacter_x000D_ formigenes serum oxalic acid and endothelial dysfunction in hemodialysis_x000D_ patients: from impaired colon to impaired endothelium. Med Hypotheses. 2015_x000D_ Mar;84(3):273-5._x000D_ _x000D_ 3: Pucci ND, Marchini GS, Mazzucchi E, Reis ST, Srougi M, Evazian D, Nahas WC._x000D_ Effect of phyllanthus niruri on metabolic parameters of patients with kidney_x000D_ stone: a perspective for disease prevention. Int Braz J Urol. 2018 Jul-_x000D_ Aug;44(4):758-764._x000D_ _x000D_ 4: Messa P, Londero D, Massarino F, Paganin L, Mioni G, Zattoni F, Cannella G._x000D_ Abnormal arachidonic acid content of red blood cell membranes and main_x000D_ lithogenic factors in stone formers. Nephrol Dial Transplant. 2000_x000D_ Sep;15(9):1388-93._x000D_ _x000D_ 5: Rodgers AL, Jappie-Mahomed D, van Jaarsveld PJ. Testing the dogma that total_x000D_ phospholipid fatty acid composition of blood plays a role in kidney stone_x000D_ pathogenesis, using a high-low risk human model: results from a pilot study._x000D_ Urolithiasis. 2019 Jun;47(3):255-261._x000D_ _x000D_ 6: Yildirim N, Cengiz M. Predictive clinical factors of chronic peripheral_x000D_ neuropathy induced by oxaliplatin. Support Care Cancer. 2020_x000D_ Oct;28(10):4781-4788._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/32557758/">7: Zhang Z, Yu X, Geng X. Protective role of three differently processed corn_x000D_ bran on glucose and lipid concentrations in d-galactose-induced mice model. J_x000D_ Food Biochem. 2020 Aug;44(8):e13281. </a>_x000D_ _x000D_ <strong>Products Related to Oxalic Acid for Interference Testing </strong> <a href="https://moleculardepot.com/product-category/Interference/">: Interference</a>